Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Wisbiom logo — Pioneering the future of human health with innovative microe...

Wisbiom

Pioneering the future of human health with innovative microecological preparations and living biopharmaceuticals.

Founded 2017 Seed Total: $1.40M Biopharma, Biotechnology

General Information

Company Name Wisbiom
Founded Year 2017
Industries Biopharma, Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Wisbiom. To contact Wisbiom, visit wisbiom.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Wisbiom

Wisbiom is a pioneering microbiotherapy company that was founded in 2017. Specializing in Biopharma and Biotechnology, it is dedicated to developing innovative microecological preparations, living biopharmaceuticals (LBP), and microbiome-related products. The company recently secured a significant $1.40M in Seed Round investment on 18 December 2023, with funding from notable investors including Hengxu Capital, ELIM Capital, Sinofaith intellectual Property, and Xiu Xiu Group. Wisbiom's mission is to revolutionize human health through cutting-edge advancements in microecology, positioning itself at the forefront of the future of healthcare.

Taxonomy: microbiotherapy, microecological preparations, living biopharmaceuticals, LBP, microbiome, human health

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.40M 4
Hengxu Capital ELIM Capital
Hengxu Capital, ELIM Capital +2
18 Dec 2023

Wisbiom Alternatives & Competitors

View All Alternatives
Wisbiom vs
NTpharma
NTpharma

Delivering next-generation nanovaccines and biopharmaceuticals faster for global health protection.

Venture round
Biopharma, Biotechnology
Wisbiom vs
Mikrobiomik
Mikrobiomik Spain

rethinking microbiome

Venture round
23 employees
Biopharma, Biotechnology
Wisbiom vs
科兴生物制药股份有限公司
科兴生物制药股份有限公司 China

精益制药，精益用药，守护健康

105 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Wisbiom

Pioneering the future of human health with innovative microecological preparations and living biopharmaceuticals.
Wisbiom was founded in 2017.
Wisbiom operates in Biopharma and Biotechnology. Its work centres on microbiotherapy, microecological preparations, living biopharmaceuticals and LBP.
Wisbiom has completed 1 funding round, raising a total of $1.40M. The latest funding stage is Seed.
Top alternatives and competitors to Wisbiom include NTpharma, Mikrobiomik, 科兴生物制药股份有限公司, BiomeBank, Ostia Sciences Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wisbiom and NTpharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Wisbiom, https://bouncewatch.com/company/wisbiom, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes